Your browser doesn't support javascript.
Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease.
Alexander, James L; Selinger, Christian P; Powell, Nick.
  • Alexander JL; Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.
  • Selinger CP; Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Powell N; Department of Metabolism, Digestion and Reproduction, Imperial College London, London SW7 2AZ, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK. Electronic address: nicholas.powell@imperial.ac.uk.
Lancet Gastroenterol Hepatol ; 6(12): 987-988, 2021 12.
Article in English | MEDLINE | ID: covidwho-1751536

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Immunization, Secondary / Immunocompromised Host / COVID-19 Vaccines / COVID-19 / Immunosuppressive Agents Type of study: Prognostic study Topics: Long Covid / Vaccines Limits: Adolescent / Adult / Aged / Child / Humans / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: Lancet Gastroenterol Hepatol Year: 2021 Document Type: Article Affiliation country: S2468-1253(21)00374-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Immunization, Secondary / Immunocompromised Host / COVID-19 Vaccines / COVID-19 / Immunosuppressive Agents Type of study: Prognostic study Topics: Long Covid / Vaccines Limits: Adolescent / Adult / Aged / Child / Humans / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: Lancet Gastroenterol Hepatol Year: 2021 Document Type: Article Affiliation country: S2468-1253(21)00374-5